HIGHLIGHTS
- who: Jeongjin Lee and colleagues from the Department of Health Sciences and Technology, SAIHST, Sungkyunkwan University, Irwon-ro, Seoul, Republic of Korea have published the Article: Evading Doxorubicin-Induced Systemic Immunosuppression Using Ultrasound-Responsive Liposomes Combined with Focused Ultrasound, in the Journal: Pharmaceutics 2022, 14, 2603. of /2022/
- what: The authors report a combined therapy to avoid the off-target toxicity of DOX by adapting liposomal doxorubicin and exposure. The authors comparatively evaluated the therapeutic efficacy of DOX and IMP301+US-treated groups .
- how: The authors examined the therapeutic efficacy of combined treatment . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.